Tyrosine kinase-targeting drugs-associated heart failure

BACKGROUND: The impact of cancer therapies on cardiac disease in the general adult cancer survivor population is largely unknown. Our objective was to evaluate which tyrosine kinase-targeting drugs are associated with greater risk for new-onset heart failure (HF). METHODS: A nested case–control anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gronich, N, Lavi, I, Barnett-Griness, O, Saliba, W, Abernethy, D R, Rennert, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482733/
https://www.ncbi.nlm.nih.gov/pubmed/28399109
http://dx.doi.org/10.1038/bjc.2017.88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482733/
https://www.ncbi.nlm.nih.gov/pubmed/28399109
http://dx.doi.org/10.1038/bjc.2017.88

Ejemplares similares